P

Inventor

PRAKASH THAZHA P

US89 patents
⚠️ This page may combine multiple inventors who share the name “PRAKASH THAZHA P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ISIS PHARMACEUTICALS INC

20 patents
US9181549B2Nov 10, 2015

Conjugated antisense compounds and their use

ISIS PHARMACEUTICALS INC69 citations99
US9127276B2Sep 8, 2015

Conjugated antisense compounds and their use

ISIS PHARMACEUTICALS INC136 citations99
US9005906B2Apr 14, 2015

Tetrahydropyran nucleic acid analogs

ISIS PHARMACEUTICALS INC163 citations99
US7696345B2Apr 13, 2010

Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation

ISIS PHARMACEUTICALS INC426 citations99
US7105499B2Sep 12, 2006

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

ISIS PHARMACEUTICALS INC233 citations99
US6639062B2Oct 28, 2003

Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom

ISIS PHARMACEUTICALS INC259 citations99
US6534639B1Mar 18, 2003

Guanidinium functionalized oligonucleotides and method/synthesis

ISIS PHARMACEUTICALS INC261 citations99
US6172209B1Jan 9, 2001

Aminooxy-modified oligonucleotides and methods for making same

ISIS PHARMACEUTICALS INC378 citations99
US8796437B2Aug 5, 2014

Tetrahydropyran nucleic acid analogs

ISIS PHARMACEUTICALS INC85 citations98
US7939677B2May 10, 2011

Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation

ISIS PHARMACEUTICALS INC152 citations98
US7875733B2Jan 25, 2011

Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation

ISIS PHARMACEUTICALS INC159 citations98
US7569686B1Aug 4, 2009

Compounds and methods for synthesis of bicyclic nucleic acid analogs

ISIS PHARMACEUTICALS INC501 citations98
US6147200ANov 14, 2000

2'-O-acetamido modified monomers and oligomers

ISIS PHARMACEUTICALS INC466 citations98
US6403779B1Jun 11, 2002

Regioselective synthesis of 2′-O-modified nucleosides

ISIS PHARMACEUTICALS INC82 citations97
US9181550B2Nov 10, 2015

Compositions and methods for modulating apolipoprotein (a) expression

ISIS PHARMACEUTICALS INC16 citations96
US9163239B2Oct 20, 2015

Compositions and methods for modulating apolipoprotein C-III expression

ISIS PHARMACEUTICALS INC20 citations96
US9382540B2Jul 5, 2016

Compositions and methods for modulating angiopoietin-like 3 expression

ISIS PHARMACEUTICALS INC13 citations93
US9145558B2Sep 29, 2015

Compositions and methods for modulating HBV expression

ISIS PHARMACEUTICALS INC13 citations93
US7919612B2Apr 5, 2011

2′-substituted oligomeric compounds and compositions for use in gene modulations

ISIS PHARMACEUTICALS INC14 citations92
US6593466B1Jul 15, 2003

Guanidinium functionalized nucleotides and precursors thereof

ISIS PHARMACEUTICALS INC28 citations92

IONIS PHARMACEUTICALS INC

17 patents
US10844379B2Nov 24, 2020

Conjugated antisense compounds and their use

IONIS PHARMACEUTICALS INC8 citations93
US9957504B2May 1, 2018

Compositions and methods for modulating apolipoprotein (a) expression

IONIS PHARMACEUTICALS INC8 citations93
US9932581B2Apr 3, 2018

Compositions and methods for modulating apolipoprotein C-III expression

IONIS PHARMACEUTICALS INC6 citations93
US9932580B2Apr 3, 2018

Compositions and methods for modulating HBV expression

IONIS PHARMACEUTICALS INC5 citations93
US9321799B2Apr 26, 2016

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

IONIS PHARMACEUTICALS INC17 citations93
US10570169B2Feb 25, 2020

Conjugated antisense compounds and their use

IONIS PHARMACEUTICALS INC11 citations86
US11851655B2Dec 26, 2023

Compositions and methods for modulating apolipoprotein (a) expression

IONIS PHARMACEUTICALS INC3 citations84
US11299736B1Apr 12, 2022

Conjugated antisense compounds and their use

IONIS PHARMACEUTICALS INC3 citations84
US11084844B2Aug 10, 2021

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

IONIS PHARMACEUTICALS INC8 citations84
US10927372B2Feb 23, 2021

Compositions and methods for modulating apolipoprotein C-III expression

IONIS PHARMACEUTICALS INC2 citations84
US10883104B2Jan 5, 2021

Compositions and methods for modulating apolipoprotein (a) expression

IONIS PHARMACEUTICALS INC5 citations84
US10683499B2Jun 16, 2020

Compositions and methods for modulating TTR expression

IONIS PHARMACEUTICALS INC5 citations84
US9994855B2Jun 12, 2018

Compositions and methods for modulating growth hormone receptor expression

IONIS PHARMACEUTICALS INC9 citations84
US9957292B2May 1, 2018

Compositions and methods for modulating angiopoietin-like 3 expression

IONIS PHARMACEUTICALS INC11 citations84
US9943604B2Apr 17, 2018

Targeted therapeutic nucleosides and their use

IONIS PHARMACEUTICALS INC9 citations84
US9738895B2Aug 22, 2017

Oligomeric compounds and methods

IONIS PHARMACEUTICALS INC10 citations84
US9714421B2Jul 25, 2017

Compositions and methods

IONIS PHARMACEUTICALS INC5 citations84

SWAYZE ERIC E

4 patents

PRAKASH THAZHA P

3 patents

MERCK & CO INC

2 patents

ALLERSON CHARLES

1 patent

SETH PUNIT P

1 patent

BHAT BALKRISHEN

1 patent

MANOHARAN MUTHIAH

1 patent

Showing the top 50 of 89 patents by PatentIndex Score.